Business
AstraZeneca vaccine: Two more countries restrict vaccine rollout over blood clot concerns – The Australian Financial Review
An arm’s length investigation is needed to sort out the blood clot issue plaguing the AstraZeneca vaccine, say medical experts.
It also applied to those with heparin-induced thrombocytopenia, who have an adverse immune reaction to the drug heparin and their platelet function is affected.
ATAGI reassured people there was no evidence of risk for those with a history of other clotting conditions and recommended the jabs for a list for conditions including deep venous thrombosis, a clot in the lung and low platelets.
The vaccine was also recommended for people with risk factors for clotting: such as smoking or using oral contraceptives;…
-
General17 hours agoTributes flow after Australian Paralympic bronze medallist Nicholas Hum dies aged 32
-
General13 hours agoNT’s top year 12 achievers celebrated, with some looking to pursue teaching careers
-
General13 hours agoReuven Morrison was killed in the Bondi Beach shooting one year after warning about antisemitism
-
Noosa News14 hours agoAccredited Specialists making a difference – Proctor